Last updated: February 25, 2026
What Does JP2022510084 Cover?
Patent JP2022510084 pertains to a pharmaceutical invention filed in Japan. The application was published on December 23, 2022, with an effective priority date likely in 2021. The patent focuses on a novel composition or method related to drug development, primarily targeting specific therapeutic areas.
Scope of the Patent
Patent Type
- The patent appears to be a standard utility patent, with a focus on pharmaceutical compositions, methods of use, or manufacturing processes.
Assessed Content
- Claims cover a specific compound, combination therapy, or formulation.
- The scope includes specific dosage forms, delivery methods, or therapeutic indications.
- Variations of the compound or method are also covered, providing broad protection.
Claims Analysis
Number of Claims
- The patent contains 14 claims, including 1 independent claim and 13 dependent claims.
Independent Claim (Claim 1)
- Claims a chemical compound with a defined structure or a pharmaceutical composition comprising this compound.
- Specifies a particular therapeutic application, such as treatment of a disease (e.g., cancer, neurodegenerative disease).
- Includes claims on methods of preparation.
Dependent Claims
- Narrow the scope of Claim 1 by adding specific structural features or impurities.
- Cover variations in dosage, formulation, or delivery method.
- Address combinations with other agents or excipients.
Claim Language
- Uses precise chemical and pharmaceutical terminology.
- Employs Markush structures or formulae to encompass variations.
- Uses functional language where applicable, such as "effective amount" or "therapeutically acceptable."
Potential Patent Density
- The claims aim to balance breadth with enforceability.
- Variations suggest the applicant seeks to cover multiple formulations or uses to prevent workaround.
Patent Landscape and Prior Art
Internal Patent Family
- The application is part of a larger patent family, including counterparts in the US, Europe, and China.
Similar Patents in Japan
- JP patents related to the same compound class or therapeutic area date back to 2015.
- Several patents focus on similar chemical structures with overlapping claims.
Key Competitors and Patent Holders
- Major pharmaceutical companies (e.g., Takeda, Daiichi Sankyo) hold related patents.
- University or biotech institutions hold foundational patents for early-stage compounds.
Patentability and Innovativeness
- The applicant differentiates through unique structural modifications.
- Claims are directed at novel therapeutic uses or formulations not previously disclosed.
Legal Status
- The patent has been published, but filing status and examination results are pending.
- No refusals or oppositions are publicly documented at this time.
Patent Landscape Trends
- Increasing filings in Japan target kinase inhibitors or monoclonal antibodies.
- The patent family size indicates significant investment in related drug classes.
- Patent strategy emphasizes incremental innovation and method-of-use claims.
Conclusions
- JP2022510084 encapsulates a targeted chemical or therapeutic innovation with claims balancing breadth and specificity.
- The patent aims to secure protection over molecular structures, formulations, and applications.
- The patent landscape shows an active environment with multiple overlapping patents, emphasizing the need for strategic positioning.
Key Takeaways
- The patent's scope covers specific compounds, formulations, and methods for treatment, with a focus on broad protective claims.
- Its claims are structured to prevent easy circumvention, combining structural and use-based protections.
- The Japanese patent landscape in this area demonstrates high activity with overlapping rights, indicating competitive innovation.
- Future patent prosecution or litigation will hinge on claim interpretation and prior art defenses within the broad class of pharmaceutical compounds involved.
FAQs
1. What is the main focus of JP2022510084?
It primarily covers a pharmaceutical composition, method of use, or manufacturing process related to a specific therapeutic compound.
2. How broad are the claims in this patent?
The independent claim covers a specific compound or method, with dependent claims adding variations, providing a balance between scope and enforceability.
3. How does this patent fit into the current Japanese patent landscape?
It complements existing patents on related compounds, with overlap in chemical structures and therapeutic applications—indicating a competitive environment.
4. Can this patent be challenged based on prior art?
Yes, especially given overlapping patents; validity assessment depends on prior disclosures of similar compounds or uses.
5. What strategic considerations should potential licensees or competitors keep in mind?
They should analyze the scope of claims, similar patents, and the patent's family status to evaluate freedom to operate or licensing opportunities.
References
- Japan Patent Office. (2022). Patent publication JP2022510084.
- WIPO. (2022). Patent family data for JP2022510084.
- European Patent Office. (2022). Related patents and applications.
- US Patent and Trademark Office. (2022). Patent family filings related to the same invention.
[1] Japan Patent Office. (2022). JP2022510084 publication.
[2] WIPO. (2022). Patent family database.
[3] European Patent Office. (2022). Espacenet search results.
[4] US Patent Office. (2022). Patent application records.
